A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Targeted cancer therapies are the next frontier of treatment, but room to innovate and improve chemotherapy in the mean time

by Doug Beaudoin, Principal, Deloitte Consulting LLP

It is exciting to learn about new discoveries and breakthroughs in cancer treatment. Certainly the research community has made great strides in both prevention and treatment. The field of immunotherapy is striving to make the patient’s immune system fight back against cancer cells. Researchers have found that combining drugs with different targets can have positive results,

Read more

For biopharma, value-based competition is likely the new reality regardless of policy

by Ralph Marcello, Principal, Deloitte Consulting LLP Click here to see the infographic

Many biopharma companies are under growing pressure from policy makers on both sides of the aisle – as well as from state and federal regulators and lawmakers – to demonstrate greater value from drug spend. While many can agree the health care system could benefit from reduced drug spending,

Read more

Albert Einstein knew

by Bill Copeland, Vice Chairman, US Life Sciences & Health Care Industry Leader, Deloitte LLP

After months of congressional efforts to repeal and replace the Affordable Care Act (ACA), it appears we now have an opportunity for a broad and much needed dialogue about our system of health care financing – as well as new clinical delivery models. The acute health care affordability crisis we now face has never been more challenging.

Read more

Innovations in infant monitoring devices

by Doug Beaudoin, Principal, Deloitte Consulting LLP

Inc. magazine released its 11th annual 30 Under 30 list featuring young entrepreneurs working to solve some of the world’s biggest challenges. The founders of Neopenda made the list – the startup makes wearables that monitor four newborn vitals in developing countries. The women who founded Neopenda, which launched in 2015,

Read more

In Israel, many LSHC “hammers” are searching for a nail

by Arod Balissa, Cyber & Health Sector Manager, Innovation Tech Terminal, Deloitte Israel

With more startup companies per capita than anywhere in the world, Israel is sometimes referred to as “the startup nation.” There are approximately 1,400 companies in the life sciences and health care (LSHC) sector alone,1 and 350 multi-national research and development (R&D) centers.2 While innovation is typically strongly encouraged in Israel, there is little domestic demand for LSHC solutions,

Read more

Hotspotting helped show us the link between social determinants and health…so how do we fix it?

by Sarah Thomas, Managing Director, Deloitte Center for Health Solutions, Deloitte Services LP

It has been about six years since Atul Gawande, MD – a surgeon, writer, and public health researcher – profiled Jeffrey Brenner, MD, in an article in The New Yorker. Dr. Brenner used advanced analytics to identify patterns underlying health care utilization data, which he dubbed “hotspotting” It’s a term used by some police departments to identify high-crime areas.

Read more